NUP214 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.434800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.256600E-01
Normal-vs-Stage2
3.333200E-01
Normal-vs-Stage3
8.967700E-02
Normal-vs-Stage4
3.563000E-01
Stage1-vs-Stage2
4.365000E-01
Stage1-vs-Stage3
1.194010E-01
Stage1-vs-Stage4
5.985000E-01
Stage2-vs-Stage3
4.371600E-02
Stage2-vs-Stage4
8.574600E-01
Stage3-vs-Stage4
8.856000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.387600E-01
Normal-vs-AfricanAmerican
3.268000E-01
Normal-vs-Asian
3.857000E-01
Caucasian-vs-AfricanAmerican
8.571400E-01
Caucasian-vs-Asian
5.254600E-01
AfricanAmerican-vs-Asian
5.424600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.396600E-01
Normal-vs-Female
3.473600E-01
Male-vs-Female
7.945000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.576600E-01
Normal-vs-Age(41-60Yrs)
3.896400E-01
Normal-vs-Age(61-80Yrs)
3.182800E-01
Normal-vs-Age(81-100Yrs)
3.269000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.288400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.897000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.056600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.491500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.415000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.969800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.767200E-01
Normal-vs-Daily Drinker
3.569600E-01
Normal-vs-Weekly Drinker
3.592200E-01
Normal-vs-Occasional Drinker
3.280400E-01
Normal-vs-Social Drinker
4.814000E-01
Non Drinker-vs-Daily Drinker
1.339210E-01
Non Drinker-vs-Weekly Drinker
1.494200E-01
Non Drinker-vs-Occasional Drinker
2.708200E-01
Non Drinker-vs-Social Drinker
5.362500E-03
Daily Drinker-vs-Weekly Drinker
9.674600E-01
Daily Drinker-vs-Occasional Drinker
6.309400E-01
Daily Drinker-vs-Social Drinker
1.457240E-01
Weekly Drinker-vs-Occasional Drinker
5.635200E-01
Weekly Drinker-vs-Social Drinker
1.464850E-01
Occasional Drinker-vs-Social Drinker
3.465700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.532600E-01
Normal-vs-Grade 2
6.768600E-01
Normal-vs-Grade 3
6.745000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.693000E-01
Grade 1-vs-Grade 3
6.098800E-01
Grade 1-vs-Grade 4
2.532600E-01
Grade 2-vs-Grade 3
9.429800E-01
Grade 2-vs-Grade 4
6.768600E-01
Grade 3-vs-Grade 4
6.745000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.902000E-01
Normal-vs-NonDiabetic
3.571800E-01
Diabetic-vs-NonDiabetic
4.301600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.406600E-01
Normal-vs-NoPancreatitis
3.375400E-01
Pancreatitis-vs-NoPancreatitis
9.932200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.650200E-01
Normal-vs-N1
3.285600E-01
N0-vs-N1
2.555600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.920200E-01
Normal-vs-TP53-NonMutant
3.512000E-01
TP53-Mutant-vs-TP53-NonMutant
1.474620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
